Article
This Is No Time to Be Buying Pfizer
The company's fairly valued already, and at least one of its blockbuster drugs, Lipitor, is looking vulnerable.
07:39AM 10/22/01
TheStreet Premium Services
Jim Cramer's Action Alerts PLUS:
Trade right alongside a Wall Street pro — enjoy access to his Charitable Trust portfolio and be sent trade alerts BEFORE he makes a move. Learn More
OptionsProfits:
Get 50+ trade ideas a week from the industry's top options experts. Plus — exclusive commentary on market trends and essential trading tools. Learn More
Real Money:
Our team of professional Wall Street Pros — including Jim Cramer, Doug Kass, and Nicholas Vardy — delivers intelligent analysis, timely trade ideas, and colorful commentary. Learn More
Stocks Under $10:
Break into the market with small- and mid-cap stocks... all $10 or less! David Peltier tells you exactly which low-priced stocks he's buying and selling. Learn More| Dow Jones | S&P 500 | NASDAQ | 10-Year Note |
|
|---|---|---|---|---|
| 12,489.64 | 1,319.08 | 2,839.57 | 17.72 |
Oil *
106.51
|
|
DOWN
6.51 |
UP
0.22 |
DOWN
10.55 |
UP
0.51 |
10 Yr
1.77%
SPDR Gold
152.46
|
|
-0.05%
|
+0.02%
|
-0.37%
|
+2.96%
|
Data delayed 20 minutes |
Connect with TheStreet